DELIVERY APPLICATOR FOR RADIOACTIVE STAPLES FOR BRACHYTHERAPY MEDICAL TREATMENT
An instrument used for brachytherapy delivery in the treatment of cancer by radiation therapy including a handle having first and second handle actuators; an end effector; and an instrument shaft that connects the handle with the end effector. The end effector has first and second adjacent disposed staple cartridges that each retain a set of staples. The first mechanism is for holding standard staples in a first array, and dispensing the standard staples under control of the corresponding first handle actuator. The second mechanism is for holding radioactive source staples in a second array, and dispensing said radioactive source staples under control of the corresponding second handle actuator. The actuating device is removably attachable to an actuator arm on a proximal end. A staple applicator cartridge holder is attached to the actuator arm on a distal end. The staple applicator cartridge is mountable in the holder and having a plurality of slots for mounting of radioactive source staples therein. An anvil therein crimps the staples.
The present invention relates to an improved method and system for applying a radioactive source to a tissue site. More particularly, the present invention pertains to an improved delivery system based upon the incorporation of a radioactive seed by fastening means, such as a surgical staple. More specifically, the present invention pertains to an improved brachytherapy delivery system for applying a radioactive source to a tissue site. Even more particularly the present invention relates to a new instrument construction wherein a single stapler instrument is used for precisely applying both standard surgical staples, as well as brachytherapy source staples relative to a surgical margin.
BACKGROUND AND OBJECTS OF THE INVENTIONThe incidence of lung cancer has been rising over the last half century, although the rate has decreased somewhat over the last decade because of increased publicity about the health risks. The American Cancer Society estimates the number of new cases in 2009 to exceed 219,000. Lung cancer is the leading cause of cancer deaths in the United States among both men and women, expected to reach 159,000 in 2009, claiming more lives than colon, prostate and breast cancer combined.i
Non-small cell lung cancer (NSCLC) is the most commonly diagnosed form of the disease, affecting 4 out of 5 patients. In United States, ˜23% of patients present with early-stage (T1, T2) disease.ii In most cases, early stage NSCLC can be treated successfully with surgery if the cancer has not spread beyond the chest. Surgical resection is the definitive treatment and lobectomy is the procedure of choice.iii,iv,v Lobectomy is the most common type of lung cancer surgery, involving removal of an entire lobe of one lung. For these early stage NSCLC patients, lobectomy yields a 5-year survival rate of 65-77%. Locoregional recurrence occurs in 28% of T1N0 tumors submitted to thoractomy, with the highest initial failure rates detected in the ipsilateral hemithorax.vi,vii Unfortunately, some patients with this disease are poor candidates for lobectomy due to poor pulmonary health or other medical issues.
Stage I NSCLC patients with compromised cardiopulmonary status may undergo limited surgical resections in an attempt at lung preservation while achieving adequate resection margins.viii However, lesser resections have been associated with an increased risk of local recurrence, even for small peripheral tumors.ix Nonetheless, limited resection is viewed as an acceptable alternative for patients with poor physiologic reserve or of advanced age.x,xi
Though sublobar resection alone is associated with an increased incidence of post-operative disease recurrence, it is still advocated for high-risk patients in the absence of a good alternative. External beam radiation therapy has been used successfully to reduce the risk of local recurrence in these compromised patients.xii However, external beam radiation therapy further reduces pulmonary function because it generally requires the beam to pass through normal lung tissue to reach the target lesion. Some studies suggest that adding brachytherapy to the regimen can make a dramatic difference in outcomes.
Intraoperative brachytherapy has been shown to be an effective therapeutic modality for patients unable to undergo a surgical lobectomy; it is an alternative to external beam irradiation for patients who cannot tolerate further loss of lung function.xiii,xiv
The use of brachytherapy has been shown in several studies to have a clinical benefit for compromised lung cancer patients for whom more traditional surgical procedures, such as a lobectomy, are not an option. This is now the subject of a NIH-sponsored Phase III Clinical trial.xv
These candidate patients would undergo limited (sublobar) surgical resection (wedge resection) in an attempt at lung preservation while achieving adequate resection margins, followed by brachytherapy; Currently, brachytherapy is performed using 125Iodine seeds delivered at the time of surgery. Seeds have been deployed by a variety of techniques such as manually suturing stranded seeds,xvi manually delivering loose seeds via a Mick® applicator,xvii thoracoscopic placement of vicryl mesh imbedded with 125Iodine radioactive seeds,xviii and seed placement in the wedge resection margin using the da Vinci robotic system.xix
The problem with all of these techniques is the difficulty in precisely delivering the brachytherapy seeds intraoperatively to achieve the proper dose distribution and minimizing the radiation dose to the clinicians performing the procedure.
When removing non-small cell lung cancers, the most prevalent form of lung cancer, conventional staples are typically used for the procedure. Moreover, the use of radioactive sources are placed near the cancer site to provide a mode of treatment. In this regard, U.S. Pat. Nos. 7,604,586 and 7,972,260 disclose one mode of treatment using staples containing a radioactive material and the attachment of these staples near the surgical resection. Reference may also be made to the aforementioned patents for background discussions pertaining to brachytherapy procedures.
Accordingly, there is a need for a staple delivery applicator having means for the accurate placement of radioactive staples at surgical sites.
Another object of the present invention to provide an apparatus or instrument for incorporating a radioactive source into or with a surgical procedure means such as a surgical staple so that the radioactive source can be positioned substantially concurrently with the application of the surgical tissue securing means.
Still another object of the present invention is to provide a brachytherapy source-delivery system and instrument that facilitates the precise placement of brachytherapy sources relative to a surgical margin, assures the seeds remain fixed in their precise position for the duration of the treatment, overcomes the technical difficulties of manipulating the seeds through a narrow surgical incision inherent in minimally invasive procedures, and at the same time reduces the radiation dose to the clinicians.
A further object of the present invention is to provide a means for irradiating cancer tissue with the use of staples in lung, colorectal and gynecological cancers, for example.
It is another object of the present invention to provide an effective therapeutic modality for patients unable to undergo a surgical lobectomy; it is an alternative to external beam irradiation for patients who cannot tolerate further loss of lung function.
It is a further object of the present invention to provide a means to precisely deliver the brachytherapy sources intraoperatively to achieve the proper dose distribution and minimizing the radiation dose to the clinicians performing the procedure.
It is still a further object of the present invention to provide a means for precise placement of brachytherapy sources relative to the surgical margin, assuring the sources remain fixed in their precise positions for the duration of the treatment, overcoming the technical difficulties of manipulating the sources through the narrow surgical incision, and reducing the radiation dose to the clinicians.
It is yet a further object of the present invention to provide a delivery device having better shielding than the existing stapler cartridges, thereby providing greater safety to the physician and other operating room personnel.
It is yet a further object of the present invention to provide a device that reduces the possibility of mis-locating sources by reducing and/or by limiting the number of potential source positions to only dosimetrically useful positions, rather than all staple positions, and further locating the sources nearer to the center of the treatment volume rather than at its edge.
SUMMARY OF THE INVENTIONThe present invention facilitates the precise placement of, for example, 125Iodine seeds relative to the surgical margin, assures the seeds remain fixed in their precise position for the duration of the treatment, overcomes the technical difficulties of manipulating the seeds through the narrow surgical incision, and reduces the radiation dose to the clinicians. The concepts of the present invention incorporate the radioactive 125Iodine seeds into a fastening means, preferably surgical staples, used in the surgical procedure. In this way, the seeds are concurrently secured in position directly adjacent to the surgical resection and remain immobile. They are precisely located relative to the resection, placed by a very convenient method eliminating the difficulties of working through the narrow surgical incision. The seed position is rigidly fixed, assuring that the dose distribution does not uncontrollably change over the duration of the treatment. This method permits the dose distribution to be precisely planned prior to the surgery to achieve the desired result. Insertion of the seeds in conjunction with the application of the staples also significantly reduces the dose to the clinician.
In accordance with the present invention the source delivery system is used in conjunction with a standard surgical stapling instrument, such as one that is presently used for video-assisted thoracoscopic surgery (VATS). By integrating a permanent brachytherapy source in a standard surgical stapling instrument, there is provided a single instrument to cut and seal lung tissue and simultaneously place a permanent radioactive seed implant. With the instrument of the present invention: (1) The source/staple does not compromise the pre-established parameters of standard surgical staple delivery systems; (2) Uses preferably the same materials, measurements, and spacing of existing surgical staples; (3) Is deliverable using currently available surgical spacing instruments; (4) Is easily assembled with the standard stapler cartridge and is readily sterilized; and (5) Can be deliverable with minimal radiation exposure to the physician and other operating-room personnel.
A staple delivery applicator for delivering radioactive staples during brachytherapy medical treatment has an actuating device for attaching source staples located distally from the actuating device. The actuating device is removably attachable to an actuator arm on a proximal end. A staple applicator cartridge holder is attached to the actuator arm on a distal end. The staple applicator cartridge is mountable in the holder and having a plurality of slots for mounting of radioactive source staples therein. An anvil therein crimps the staples. The staple applicator cartridge holder is removably mountable in a connector and the connector is also removably mounted to a surgical staple holder. In one embodiment a trigger device has a control for closing the anvil of the cartridge holder and for firing of the source staples in the cartridge therein to cause the staples to crimp, and a control for opening the anvil and releasing the trigger device from the actuator arm.
Numerous other objects, features and advantages of the present invention are now realized by a reading of the following detailed description taken in conjunction with the accompanying drawings, in which:
Like reference numerals refer to like parts throughout the several views of the drawings.
DETAILED DESCRIPTIONAn objective of the present invention is to develop an improved delivery system based upon the incorporation of a radioactive seed into fastening means, preferably into a surgical staple. More particularly the disclosed system is an improved brachytherapy delivery system for treatment of, inter alia, lung cancer based upon the incorporation of radioactive seeds into surgical staples used in lung resection. For patients with compromised cardiopulmonary status, the inclusion of brachytherapy with sublobular resection has shown a significant improvement in therapeutic outcome over sublobular resection alone. This present technique facilitates the delivery of this therapy. Furthermore, the techniques described herein may also be used in other medical procedures. Moreover, the techniques of the present invention may be used in applying a variety of radioactive sources.
The technique of the present invention facilitates the precise placement of, for example, 125Iodine seeds relative to the surgical margin, assures the seeds remain fixed in their precise position for the duration of the treatment, overcomes the technical difficulties of manipulating the seeds through the narrow surgical incision, and reduces the radiation dose to the clinicians. The examples describe the use of Iodine-125 as the radiation source but this is understood to be illustrative and that any radionuclide commonly used for brachytherapy, including Palladium-103, Cesium-131 and Ytterbium-169 could be incorporated into these staple/sources.
The present invention develops a brachytherapy system that can be used for intraoperative placement of radioactive seeds simultaneously with fastener means, preferably surgical staples, used in lung wedge resection procedures. Such a instrument precisely fixes the position of the seeds relative to the resection margin and provide a well defined, stable dose distribution to the target, while facilitating the means for delivering these seeds with reduced dose to the physicians. In one embodiment this is performed by having the radiation source integral with the fastener or staple so that when the resection occurs, concurrently therewith, the radiation source is properly positioned.
The instrument of the present invention permits delivery of the seeds and surgical staples using currently-available surgical stapling instruments modified in accordance with the principles of the present invention. The seed/staple combination is easily assembled with the staple cartridge. The combination is readily sterilizable. The combination is deliverable with minimal radiation exposure to the physician. The design of any additional structure around the 125Iodine seed should be sensitive to excessive modulation of the dosimetric parameters of the seed. Refer to
One embodiment of a source staple is shown in
An alternative embodiment, as shown in
In most brachytherapy situations, this treatment plan could be performed using a standard treatment planning system.
The cartridges for the surgical staples may be molded in plastic. This material does not provide any appreciable shielding, even for such a low energy radionuclide as 125Iodine. However, high density plastics containing tungsten are available and are regularly used for radiation shielding for 125Iodine seeds. We would plan to fabricate the special cartridge using this type of plastic. The cartridge would be designed to provide adequate shielding for the clinicians handling this instrument during the surgical procedure.
Another embodiment in accordance with the present invention is shown in
Reference is now made to
In the embodiment shown in
The concepts of the present invention are described in connection with a lung brachytherapy. In this connection reference is made to the schematic diagram of
Before discussing the particular stapler construction of the present invention, reference is now made to
Reference is now made to a surgical stapling instrument 80 illustrated in
In
Reference is now also made to
The stapling sequence, particularly between standard and source staples, can be performed in a number of different ways. Usually, the standard staples are first applied followed by the application of the source staples. However, it is also possible to provide concurrent lever actuation so that a source staple is applied at the same time as the standard staple. In a preferred technique, the instrument progresses along the surgical margin closing the tissue. Once a set of staples has been fastened in the pattern previously described, then the surgeon can basically progress along the same path applying the therapeutic source staples with the same basic instrument but actuating the source staple part of the end effector. Thereafter, the stapling instrument may be moved to a different location and this type of dual action repeated.
The staple delivery applicator 110 is composed of a trigger device 112 and a cartridge unit 114,
Referring to
The trigger device 112 as shown above is one embodiment of an actuating means or device for operating the cable 136 in the actuating arm 122. Referring to
To better understand the operation of the applicator 110,
In one embodiment as best shown in
Currently, surgical staples are delivered by a wedge-shaped driving element within the cartridge which presses a piston through the cartridge cavity causing the staples to be pressed against an anvil 160 causing the staple legs to be bent over within an anvil bending device such as seen in a common stapler.
The applicator cartridge holder 174 is attached to either the right-hand or left-hand side of the surgical stapler cartridge 150 so as to be useful on either leg/side of a typical wedge resection. Source positioning will not be restricted to the typical “1-centimeter” spacing that is currently used. The ability to have closer source positioning, especially at the ends of the line of sources, will afford the opportunity to differentially load the cartridge (i.e. have greater activity at the ends) to compensate for the dose “drop-off” typical of such an array of sources/seeds.
One embodiment of the present invention has a one-piece connector 158,
The staple delivery applicator 110 may use the connector 158,
The modular applicator connector 178 is shown in
The staple delivery applicator 110 further includes radiation shielding in either the staple cartridge 152 itself or on the applicator connector 158, preferably in the applicator cartridge 152 since the radioactive staples would be mounted there. The shielding material may be a part of the composition of the cartridge 152 or be a layer of shielding mounted thereabout. The anvil 161 of the cartridge unit 114 may also be shielded to fully prevent exposure from radiation to the operators of the staple applicator 110. The shielding would minimize the radiation dose to the physician deploying the device as well as to the other personnel in the operating room. The shielding will permit safe storage of this device in the Operating Room until it is time for use. The device will also be designed for sterilization, and resterilization, using steam, ethylene oxide and gamma radiation to provide total flexibility to the hospital.
Since many modifications, variations, and changes in detail can be made to the described embodiments of the invention, it is intended that all matters in the foregoing description and shown in the accompanying drawings be interpreted as illustrative and not in a limiting sense. Thus, the scope of the invention should be determined by the appended claims and their legal equivalents.
Having now described a limited number of embodiments of the present invention, it should be apparent to those skilled in the art that numerous embodiments and modifications thereof are contemplated as falling within the scope of the present invention as defined by the appended claims.
- i Jemal, Siegel, et al. “Cancer Statistics, 2009.” CA Cancer J Clin. 2009; 59:225-249.
- ii American College of Surgeons. “National Cancer Database for 2003.”<http://www.facs.org/cancer/ncdb/index.html>.
- iii Ginsberg, R. J. and L. V. Rubinstein. “Randomized Trial of Lobectomy Versus Limited Resection for T1 N0 Non-Small Cell Lung Cancer.” Lung Cancer Study Group Ann Thorac Surg. 1995 September; 60(3):615-22.
- <K“http://ats.ctnetjournals.org/cgi/content/full/60/3/615”http://ats.ctsnetjournals.org/cgi/content/full/60/3/615>.
- iv Martini, Bains, et al. “Incidence of Local Recurrence and Second Primary Tumors in Resected Stage I Lung Cancer.” J Thorac Cardiovasc Surg. 1995 January; 109(1):120-9
- v Ichinose, Yano, et al. “The Correlation Between Tumor Size and Lymphatic Vessel Invasion in Resected Peripheral Stage I Non-Small-Cell Lung Cancer.” A potential risk of limited resection. J Thorac Cardiovasc Surg. 1994 October; 108(4):684-6.
- vi Choi, N. C. “Prospective Prediction of Postradiotherapy Pulmonary Function With Regional Pulmonary Function Data: Promise and Pitfalls.” Int J Radiat Oncol Biol Phys. 1988 July; 15(1):245-7.
- vii Ginsberg, R. J. and L. V. Rubinstein. “Randomized Trial of Lobectomy Versus Limited Resection for T1 N0 Non-Small Cell Lung Cancer.”. Lung Cancer Study Group Ann Thorac Surg. 1995 September; 60(3):615-22.
- <http://ats.ctsnetjournals.org/cgi/content/full/60/3/615>.
- viii Landreneau, Sugarbaker, et al. “Wedge Resection Versus Lobectomy for Stage I (T1 N0 M0) Non-Small-Cell Lung Cancer.” J Thorac Cardiovasc Surg. 1997 April; 113(4):691-8; discussion 698-700.
- ix Warren, W. H. and L. P. Faber. “Segmentectomy Versus Lobectomy in Patients With Stage I Pulmonary Carcinoma.” Five-Year Survival and Patterns of Intrathoracic Recurrence. J Thorac Cardiovasc Surg. 1994 April; 107(4):1087-93.
- x Landreneau, Sugarbaker, et al. “Wedge Resection Versus Lobectomy for Stage I (T1 N0 M0) Non-Small-Cell Lung Cancer.” J Thorac Cardiovasc Surg. 1997 April; 113(4):691-8; discussion. 698-700.
- xi Kodama, Doi, et al. “Intentional Limited Resection for Selected Patients With T1 N0 M0 Non-Small-Cell Lung Cancer: A Single-Institution Study.” J Thorac Cardiovasc Surg. 1997 September; 114(3):347-53.
- xii Miller, J. I. and C. R. Hatcher, Jr. “Limited Resection of Bronchogenic Carcinoma in the Patient With Marked Impairment of Pulmonary Function.” Ann Thorac Surg. 1987. October; 44(4):340-3.
- xiii Hilaris, B. S. and D. Nori. “The Role of External Radiation and Brachytherapy in Unresectable Non-Small Cell Lung Cancer.” Surg Clin North Am. 1987 October; 67(5):1061-71.
- xiv Fleischman, Kagan, et al. “Iodine125 Interstitial Brachytherapy in the Treatment of Carcinoma of the Lung.” J Surg Oncol. 1992 January; 49(1):25-8.
- xv National Cancer Institute. “Phase III Randomized Study of Sublobar Resection With Versus Without Intraoperative Brachytherapy in High-Risk Patients With Stage I Non-Small Cell Lung Cancer.” Protocol ID NCT00107172, ACOSOG-Z4032 SRCI. <http://www.cancer.gov/clinicaltrials/ACOSOG-Z4032>.
- xvi Lee, Daly, et al. “Limited Resection for Non-Small Cell Lung Cancer: Observed Local Control With Implantation of 125I Brachytherapy Seeds.” Ann Thorac Surg. 2003 January; 75(1):237-42.
- xvii Pisch, Panigrahi, et al. “I-125 Volume Implant in Stage I Lung Cancer Patients Medically Unresectable.” Endocuriether/Hypertherm Oncology 1996; 12:65-170.
- xviii Chen, Galloway, et al. “Intraoperative 125I Brachytherapy for High-Risk Stage I Non-Small Cell Lung Carcinoma.” Int J Radiat Oncol Biol Phys. 1999 Jul. 15; 44(5):1057-63.
- xix Pisch, Belsley, et al. “Placement of 125I Implants With the Da Vinci Robotic System After Video-Assisted Thoracoscopic Wedge Resection: A Feasibility Study.” Int J Radiat Oncol Biol Phys. 2004 Nov. 1; 60(3):928-32.
Claims
1. An instrument used for brachytherapy delivery in the treatment of cancer by radiation therapy, said instrument comprising:
- a handle having first and second handle actuators;
- an end effector;
- an instrument shaft that connects the handle with the end effector;
- said end effector comprised of first and second adjacent disposed cartridges that each retain a set of staples;
- said first cartridge for holding standard staples in a first array, and dispensing said standard staples under control of the corresponding first handle actuator;
- said second cartridge for holding radioactive source staples in a second array, and dispensing said radioactive source staples under control of the corresponding second handle actuator;
- said first and second cartridges being retained in a substantially parallel array so that the standard staples close the incision at a surgical margin while the source staples are secured adjacent thereto.
2. The instrument of claim 1 wherein both of said arrays of staples are disposed spaced both longitudinally and laterally.
3. The instrument of claim 1 wherein said staples are constructed of any one of platinum, titanium, nickel-titanium alloys, gold, stainless steel, palladium, silica and alumina.
4. The instrument of claim 1 wherein the staples of both arrays are spaced apart about 1.0 mm both longitudinally and laterally.
5. The instrument of claim 1 wherein said standard staples are positionable for piercing said tissue in performing a surgical procedure at a surgical margin while substantially concurrently said source staples secure said radioactive source in a fixed position at said surgical margin.
6. The instrument of claim 5 wherein said array of source staple is constructed and arranged to extend spaced longitudinally of the surgical margin.
7. The instrument of claim 1 wherein the radioactive source is for cancer treatment and the standard staples are applied followed by applying the source staples.
8. The instrument of claim 7 wherein a complete line of standard staples are applied followed by a complete line of source staples.
9. An instrument used as a brachytherapy delivery means in the treatment of cancer by radiation therapy, said apparatus comprising:
- a control handle;
- an end effector;
- an instrument shaft that connects the control handle with the end effector;
- said end effector comprised of first and second adjacently disposed cartridges that each retain a set of staples;
- said first cartridge for holding standard staples in a first array, and dispensing said standard staples under operation from said control handle;
- said second cartridge for holding radioactive source staples in a second array;
- said source staples each comprised of a base, tissue piercing ends, a radioactive source, and means for mounting the radioactive source to the base;
- said second cartridge for dispensing said source staples under operation from said control handle;
- said cartridges for retaining and selectively applying the staples along a surgical margin so that the standard staples close the incision at a surgical margin while the source staples are secured adjacent thereto.
10. The instrument of claim 9 including a distal holder for retaining the first and second cartridges in a substantially parallel array.
11. The instrument of claim 10 wherein each cartridge control handle also has respective first and second handle actuators for controlling the application of staples.
12. The instrument of claim 9 wherein said source staples fix the position of the radioactive source relative to the surgical martin to provide a stable dose distribution thereat.
13. A staple delivery applicator for delivering radioactive source staples during a medical treatment, said staple delivery applicator comprising:
- an actuating means, said actuating means for controlling crimping of the source staples located distally from said actuating means;
- an actuator arm, said actuating means being removably attachable to said actuator arm on a proximal end; and
- a cartridge holder, said cartridge holder operatively attached to said actuator arm on a distal end and adapted to removably mount therein a source staple cartridge;
- wherein said actuating means is adapted for closing the anvil of the cartridge holder and for firing of the source staples in the cartridge therein to cause the staples to crimp, and opening and closing of the anvil.
14. The staple delivery applicator for delivering radioactive source staples as recited in claim 13, wherein said actuating means comprises a device operated by hand, by mechanical means, or electrical/mechanical means.
15. The staple delivery applicator as recited in claim 14, wherein said mechanical means comprises a trigger device comprising:
- a hand holding section, a lever mounted in said hand holding section;
- a control section, said control section having one or more controls therein thereon for crimping staples located distally from said trigger device, said control section having a control for closing the anvil of the cartridge holder and for firing of the source staples in the cartridge therein to cause the staples to crimp, and a control for opening the anvil and releasing the trigger device from the actuator arm; and
- an actuator arm mounting section.
16. The staple delivery applicator as recited in claim 13, wherein said actuator arm has a proximal end and a distal end, said proximal end having a control cable extending therefrom which is mountable in said actuator arm mounting section, said distal end being adapted to mount to said cartridge holder.
17. The staple delivery applicator as recited in claim 13, wherein said cartridge holder further includes said anvil and a firing hammer, said firing hammer being translatable within said staple cartridge, said firing hammer operatively pushing upwards upon one or more staple holders mounted therein, said pushing crimping the legs of staples against said anvil.
18. The staple delivery applicator as recited in claim 13, wherein said staple cartridge may be removably attached to said cartridge holder, said staple cartridge having a plurality of slots for mounting of radioactive source staples therein, said anvil for crimping the staples therein.
19. The staple delivery applicator as recited in claim 13, further including a connector, said staple holder being adapted for removably mounting in said connector, said connector being removably mounted to a surgical staple holder.
20. The staple delivery applicator as recited in claim 19, wherein said connector may be mounted to one side or the other side of said surgical staple holder.
21. The staple delivery applicator as recited in claim 20, wherein said connector further includes radiation shielding.
22. The staple delivery applicator as recited in claim 13, further including a modular connector with two modular units, one modular unit being adapted to removably hold said source staple cartridge holder, the other modular unit being adapted to removably hold a surgical staple cartridge holder, said units being removably mounted together in said modular connector when in use.
23. The staple delivery applicator as recited in claim 21, wherein said modular unit for said cartridge holder may be mounted to either side of the modular unit for holding said surgical staple holder.
24. The staple delivery applicator as recited in claim 23, wherein said connector further includes radiation shielding.
25. The staple delivery applicator as recited in claim 13, said anvil further includes radiation shielding.
26. A staple delivery applicator for delivering radioactive staples during medical treatment, said staple delivery applicator comprising:
- an actuating means, said actuating means for controlling crimping of the source staples located distally from said actuating means;
- an actuator arm, said actuating means being removably attachable to said actuator arm on a proximal end;
- a cartridge holder, said cartridge holder operatively attached to said actuator arm on a distal end and adapted to removably mount therein a source staple cartridge;
- a connector, said staple holder being adapted to removably mount in said connector;
- wherein said actuating means is adapted for closing the anvil of the cartridge holder and for firing of the source staples in the cartridge therein to cause the staples to crimp, and opening and closing of the anvil.
27. The staple delivery applicator for delivering radioactive source staples as recited in claim 26, wherein said actuating means comprises a device operated by hand, by mechanical means, or electrical/mechanical means.
28. The staple delivery applicator as recited in claim 27, wherein said mechanical means comprises a trigger device comprising:
- a hand holding section, a lever mounted in said hand holding section;
- a control section, said control section having one or more controls therein thereon for crimping staples located distally from said trigger device, said control section having a control for closing the anvil of the cartridge holder and for firing of the source staples in the cartridge therein to cause the staples to crimp, and a control for opening the anvil and releasing the trigger device from the actuator arm; and
- an actuator arm mounting section.
29. The staple delivery applicator as recited in claim 26, wherein said connector may be mounted to one side or the other side of said surgical staple holder.
30. The staple delivery applicator as recited in claim 26, wherein said connector further includes radiation shielding.
31. The staple delivery applicator as recited in claim 26, further including a modular connector with two modular units, one modular unit being adapted to removably hold said cartridge holder, the other modular unit being adapted to removably hold a surgical staple cartridge holder, said units being removably mounted together in said modular connector when in use.
32. The staple delivery applicator as recited in claim 31, wherein said modular unit for said cartridge holder may be mounted to either side of the modular unit for holding said surgical staple holder.
33. The staple delivery applicator as recited in claim 19, wherein said modular connector further includes radiation shielding.
Type: Application
Filed: May 9, 2012
Publication Date: Jan 29, 2015
Inventors: David E. Wazer (Ashland, MA), Thomas A. DiPetrillo (Dover, MA), John J. Munro (North Andover, MA), Matthew Hollows (Westminster, MA), Kevin Schehr (New Orleans, LA), Krissie K. Zambrano (New Orleans, LA)
Application Number: 13/697,387
International Classification: A61N 5/10 (20060101); A61B 17/064 (20060101);